In last decades, mutations identified in IDH1 and IDH2, and a few other metabolic genes, such as succinate dehydrogenase (SDH) and fumarate hydratase (FH), have provided compelling evidence for metabolic alteration in human cancer development and progression. The gene discussed is IDH2; the disease is cancer.